|
drug metabolic process
|
GO:0017144 |
4 |
0.804
|
Human Mouse |
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.340
|
|
|
naphthalene metabolic process
|
GO:0018931 |
1 |
0.281
|
|
|
cation transport
|
GO:0006812 |
399 |
0.262
|
|
|
drug catabolic process
|
GO:0042737 |
2 |
0.248
|
Mouse |
|
kidney development
|
GO:0001822 |
213 |
0.223
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.197
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.172
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.154
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.138
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.129
|
|
|
cofactor metabolic process
|
GO:0051186 |
80 |
0.124
|
Human |
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.118
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.117
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.114
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.111
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.109
|
|
|
naphthalene containing compound metabolic process
|
GO:0090420 |
1 |
0.108
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.107
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.105
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.104
|
|
|
short chain fatty acid catabolic process
|
GO:0019626 |
2 |
0.103
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.100
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.100
|
|
|
renal system development
|
GO:0072001 |
225 |
0.100
|
|
|
cellular response to cadmium ion
|
GO:0071276 |
3 |
0.098
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.092
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.091
|
Human |
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.087
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.085
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.082
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.081
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.078
|
Human |
|
anion transmembrane transport
|
GO:0098656 |
71 |
0.077
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.076
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.074
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.073
|
|
|
small molecule catabolic process
|
GO:0044282 |
71 |
0.072
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.070
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.067
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.061
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.059
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.059
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.054
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.053
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.052
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.052
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.051
|
|
|
amino acid transmembrane transport
|
GO:0003333 |
37 |
0.051
|
|
|
lung development
|
GO:0030324 |
164 |
0.050
|
|
|
benzene containing compound metabolic process
|
GO:0042537 |
5 |
0.048
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.048
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.048
|
|
|
secondary alcohol metabolic process
|
GO:1902652 |
3 |
0.045
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.045
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.045
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.045
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.045
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.044
|
|
|
anion transport
|
GO:0006820 |
177 |
0.044
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.044
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.043
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.043
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.042
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.042
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.041
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.041
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.041
|
|
|
icosanoid metabolic process
|
GO:0006690 |
33 |
0.041
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.040
|
|
|
unsaturated fatty acid metabolic process
|
GO:0033559 |
31 |
0.039
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.039
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.038
|
|
|
fat soluble vitamin biosynthetic process
|
GO:0042362 |
4 |
0.037
|
|
|
circadian regulation of gene expression
|
GO:0032922 |
48 |
0.037
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.037
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.036
|
Human |
|
sulfate assimilation
|
GO:0000103 |
3 |
0.036
|
|
|
calcitriol biosynthetic process from calciol
|
GO:0036378 |
3 |
0.035
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.035
|
|
|
cellular alcohol metabolic process
|
GO:0044107 |
3 |
0.035
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.035
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.034
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.034
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.034
|
|
|
energy derivation by oxidation of organic compounds
|
GO:0015980 |
77 |
0.034
|
|
|
vitamin d biosynthetic process
|
GO:0042368 |
3 |
0.033
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.033
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.033
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.033
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.032
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.032
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.032
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.032
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.032
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.032
|
|
|
midgut development
|
GO:0007494 |
4 |
0.032
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.032
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.031
|
|
|
coenzyme metabolic process
|
GO:0006732 |
52 |
0.031
|
Human |
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.031
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.031
|
|
|
acetylcholine catabolic process
|
GO:0006581 |
1 |
0.031
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.031
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
61 |
0.030
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.029
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.029
|
|
|
oxygen metabolic process
|
GO:0072592 |
4 |
0.029
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.029
|
|
|
estrogen secretion
|
GO:0035937 |
1 |
0.029
|
|
|
regulation of renal sodium excretion
|
GO:0035813 |
3 |
0.029
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.028
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.028
|
|
|
isoprenoid metabolic process
|
GO:0006720 |
29 |
0.028
|
|
|
response to nitrosative stress
|
GO:0051409 |
1 |
0.028
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.028
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.028
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.028
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.027
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.027
|
|
|
carboxylic acid catabolic process
|
GO:0046395 |
51 |
0.027
|
|
|
vitamin d3 metabolic process
|
GO:0070640 |
3 |
0.027
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.027
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.026
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.026
|
|
|
calcium ion transmembrane transport
|
GO:0070588 |
85 |
0.026
|
|
|
renal tubular secretion
|
GO:0097254 |
2 |
0.026
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.026
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.025
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.025
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.025
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.025
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.025
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.025
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.024
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.024
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.024
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.024
|
|
|
carnitine transport
|
GO:0015879 |
3 |
0.024
|
|
|
amino acid transport
|
GO:0006865 |
61 |
0.024
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.024
|
|
|
gland development
|
GO:0048732 |
330 |
0.024
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.024
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.024
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.024
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.024
|
|
|
regulation of neurotransmitter uptake
|
GO:0051580 |
6 |
0.024
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.023
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.023
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.023
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.023
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.023
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.023
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.023
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.023
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.023
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.023
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.023
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.023
|
|
|
organic acid catabolic process
|
GO:0016054 |
51 |
0.023
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.023
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.023
|
|
|
fatty acid derivative metabolic process
|
GO:1901568 |
33 |
0.023
|
|
|
monocarboxylic acid transport
|
GO:0015718 |
44 |
0.022
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.022
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.022
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.022
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.022
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.022
|
|
|
skin development
|
GO:0043588 |
220 |
0.022
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.022
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.022
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.022
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.022
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.022
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.021
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.021
|
|
|
cellular alcohol biosynthetic process
|
GO:0044108 |
3 |
0.021
|
|
|
angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure
|
GO:0001998 |
3 |
0.021
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.021
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.021
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.021
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.021
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.021
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.021
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.021
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.020
|
|
|
regulation of neurotransmitter levels
|
GO:0001505 |
87 |
0.020
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.020
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.020
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.020
|
|
|
sulfur compound biosynthetic process
|
GO:0044272 |
37 |
0.020
|
|
|
neurotransmitter uptake
|
GO:0001504 |
14 |
0.020
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.020
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.020
|
|
|
lung alveolus development
|
GO:0048286 |
45 |
0.020
|
|
|
phenol containing compound metabolic process
|
GO:0018958 |
60 |
0.020
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.020
|
|
|
bronchiole development
|
GO:0060435 |
3 |
0.020
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.020
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.020
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.019
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.019
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.019
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.019
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.019
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.019
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.019
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.018
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.018
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.018
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.018
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.018
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.018
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.018
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.018
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.018
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.018
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.018
|
|
|
receptor biosynthetic process
|
GO:0032800 |
3 |
0.018
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.018
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.018
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.018
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.018
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.018
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.018
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.017
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.017
|
|
|
mitotic cytokinesis
|
GO:0000281 |
4 |
0.017
|
|
|
negative regulation of protein complex disassembly
|
GO:0043242 |
22 |
0.017
|
|
|
regulation of membrane protein ectodomain proteolysis
|
GO:0051043 |
3 |
0.017
|
|
|
female meiosis chromosome segregation
|
GO:0016321 |
1 |
0.017
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.017
|
|
|
type b pancreatic cell proliferation
|
GO:0044342 |
10 |
0.017
|
|
|
cellular amide metabolic process
|
GO:0043603 |
58 |
0.017
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.017
|
|
|
regulation of ion transmembrane transporter activity
|
GO:0032412 |
54 |
0.017
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.017
|
|
|
sodium ion transport
|
GO:0006814 |
73 |
0.017
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.017
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.017
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.017
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.017
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.017
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.017
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.017
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.017
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.017
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.017
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.017
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.017
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.016
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.016
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.016
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.016
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.016
|
|
|
leukocyte chemotaxis
|
GO:0030595 |
69 |
0.016
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.016
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.016
|
|
|
terpenoid metabolic process
|
GO:0006721 |
25 |
0.016
|
|
|
positive regulation of blood pressure
|
GO:0045777 |
21 |
0.016
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.016
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.016
|
|
|
heme metabolic process
|
GO:0042168 |
16 |
0.016
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.016
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.016
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.016
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.016
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.016
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.016
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.016
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.016
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.016
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.016
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.016
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.016
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.016
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.015
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.015
|
|
|
elastic fiber assembly
|
GO:0048251 |
4 |
0.015
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.015
|
|
|
renal system process
|
GO:0003014 |
48 |
0.015
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.015
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.015
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.015
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.015
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.015
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.015
|
|
|
response to xenobiotic stimulus
|
GO:0009410 |
13 |
0.015
|
Human |
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.015
|
|
|
carnitine metabolic process
|
GO:0009437 |
7 |
0.015
|
|
|
neuron death
|
GO:0070997 |
154 |
0.015
|
|
|
regulation of estrogen secretion
|
GO:2000861 |
1 |
0.015
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.015
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.015
|
|
|
inorganic anion transmembrane transport
|
GO:0098661 |
29 |
0.015
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.015
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.015
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.015
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.015
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.015
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.015
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.015
|
|
|
fat cell proliferation
|
GO:0070341 |
4 |
0.015
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.015
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.015
|
|
|
response to drug
|
GO:0042493 |
75 |
0.015
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.014
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.014
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.014
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.014
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.014
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.014
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.014
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.014
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.014
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.014
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.014
|
|
|
apical constriction
|
GO:0003383 |
4 |
0.014
|
|
|
regulation of lymphocyte apoptotic process
|
GO:0070228 |
41 |
0.014
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.014
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.014
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.014
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.014
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.014
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.014
|
|
|
regulation of fat cell proliferation
|
GO:0070344 |
4 |
0.014
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.014
|
|
|
notch signaling pathway
|
GO:0007219 |
71 |
0.014
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.014
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.014
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.014
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.014
|
|
|
positive regulation of epithelial cell proliferation involved in lung morphogenesis
|
GO:0060501 |
3 |
0.014
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.014
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.014
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.014
|
|
|
response to osmotic stress
|
GO:0006970 |
21 |
0.013
|
|
|
protein complex disassembly
|
GO:0043241 |
40 |
0.013
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.013
|
|
|
lymphocyte apoptotic process
|
GO:0070227 |
54 |
0.013
|
|
|
long chain fatty acid metabolic process
|
GO:0001676 |
26 |
0.013
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.013
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.013
|
|
|
body fluid secretion
|
GO:0007589 |
53 |
0.013
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
63 |
0.013
|
|
|
neurotransmitter transport
|
GO:0006836 |
76 |
0.013
|
|
|
asymmetric neuroblast division
|
GO:0055059 |
1 |
0.013
|
|
|
inter male aggressive behavior
|
GO:0002121 |
3 |
0.013
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.013
|
|
|
sterol homeostasis
|
GO:0055092 |
45 |
0.013
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.013
|
|
|
regulation of t cell anergy
|
GO:0002667 |
4 |
0.013
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.013
|
|
|
ceramide catabolic process
|
GO:0046514 |
7 |
0.013
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.013
|
|
|
fatty acid transport
|
GO:0015908 |
28 |
0.013
|
|
|
rna processing
|
GO:0006396 |
105 |
0.013
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.013
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.013
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.013
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.013
|
|
|
leukocyte homeostasis
|
GO:0001776 |
79 |
0.013
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.013
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.013
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
59 |
0.013
|
|
|
cognition
|
GO:0050890 |
149 |
0.013
|
|
|
polyol metabolic process
|
GO:0019751 |
26 |
0.013
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.013
|
|
|
lymphocyte homeostasis
|
GO:0002260 |
64 |
0.012
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.012
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.012
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.012
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.012
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.012
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.012
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.012
|
|
|
aldehyde catabolic process
|
GO:0046185 |
4 |
0.012
|
|
|
sodium ion transmembrane transport
|
GO:0035725 |
49 |
0.012
|
|
|
endothelial cell migration
|
GO:0043542 |
44 |
0.012
|
|
|
short chain fatty acid metabolic process
|
GO:0046459 |
6 |
0.012
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.012
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.012
|
|
|
response to stilbenoid
|
GO:0035634 |
22 |
0.012
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.012
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.012
|
|
|
sodium ion export
|
GO:0071436 |
2 |
0.012
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.012
|
|
|
pyridine nucleotide catabolic process
|
GO:0019364 |
3 |
0.012
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.012
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.012
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.012
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.012
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.012
|
|
|
peptide metabolic process
|
GO:0006518 |
46 |
0.012
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.012
|
|
|
positive regulation of stem cell proliferation
|
GO:2000648 |
59 |
0.012
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.012
|
|
|
receptor mediated endocytosis
|
GO:0006898 |
51 |
0.012
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.012
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.012
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.012
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.012
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.012
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.012
|
|
|
succinyl coa metabolic process
|
GO:0006104 |
1 |
0.012
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.012
|
|
|
tetrapyrrole metabolic process
|
GO:0033013 |
22 |
0.012
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.012
|
|
|
regulation of endothelial cell migration
|
GO:0010594 |
22 |
0.012
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.012
|
|
|
endocrine hormone secretion
|
GO:0060986 |
15 |
0.012
|
|
|
mesenchymal epithelial cell signaling involved in lung development
|
GO:0060496 |
1 |
0.012
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.012
|
|
|
cyclic purine nucleotide metabolic process
|
GO:0052652 |
43 |
0.012
|
|
|
regulation of mesenchymal cell proliferation
|
GO:0010464 |
37 |
0.012
|
|
|
pigment metabolic process
|
GO:0042440 |
32 |
0.012
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
11 |
0.011
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.011
|
|
|
branch elongation involved in salivary gland morphogenesis
|
GO:0060667 |
2 |
0.011
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.011
|
|
|
amino acid betaine metabolic process
|
GO:0006577 |
7 |
0.011
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.011
|
|
|
operant conditioning
|
GO:0035106 |
2 |
0.011
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.011
|
|
|
dopamine uptake
|
GO:0090494 |
4 |
0.011
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.011
|
|
|
adult locomotory behavior
|
GO:0008344 |
91 |
0.011
|
|
|
catecholamine uptake
|
GO:0090493 |
4 |
0.011
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.011
|
|
|
rap protein signal transduction
|
GO:0032486 |
3 |
0.011
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.011
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.011
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.011
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.011
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.011
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.011
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.011
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.011
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.011
|
|
|
learning
|
GO:0007612 |
98 |
0.011
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.011
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.011
|
|
|
negative regulation of cellular response to growth factor stimulus
|
GO:0090288 |
46 |
0.011
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.011
|
|
|
cellular lipid catabolic process
|
GO:0044242 |
52 |
0.011
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.011
|
|
|
porphyrin containing compound metabolic process
|
GO:0006778 |
22 |
0.011
|
|
|
positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002824 |
61 |
0.011
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.011
|
|
|
renal sodium excretion
|
GO:0035812 |
3 |
0.011
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.011
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.011
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.011
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.011
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.011
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.011
|
|
|
submandibular salivary gland formation
|
GO:0060661 |
1 |
0.011
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.011
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
59 |
0.011
|
|
|
regulation of circadian sleep wake cycle
|
GO:0042749 |
3 |
0.011
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.011
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.011
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.011
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.011
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.011
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
74 |
0.011
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.011
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.011
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.011
|
|
|
positive regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090100 |
43 |
0.011
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.010
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.010
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.010
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.010
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.010
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.010
|
|
|
transition metal ion homeostasis
|
GO:0055076 |
54 |
0.010
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.010
|
|
|
response to temperature stimulus
|
GO:0009266 |
55 |
0.010
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.010
|
|
|
regulation of epithelial cell migration
|
GO:0010632 |
35 |
0.010
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.010
|
|
|
regulation of nucleotide biosynthetic process
|
GO:0030808 |
34 |
0.010
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.010
|
|
|
renal system process involved in regulation of blood volume
|
GO:0001977 |
4 |
0.010
|
|
|
semicircular canal fusion
|
GO:0060879 |
1 |
0.010
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.010
|
|